Metsera to Present at Upcoming September Investor Conferences

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera” or the “Company”), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced that Whit Bernard, its Chief Executive Officer, will present at the following investor conferences: Cantor Global Healthcare Conference 2025Wednesday, September 33:20 – 3:50 P.M. EDT Wells Fargo 2025 Healthcare ConferenceThursday, September 44:30 – 5:05 P.M. EDT A liv ...